BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22981610)

  • 1. Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy.
    Chang JS; Lim JS; Noh SH; Hyung WJ; An JY; Lee YC; Rha SY; Lee CG; Koom WS
    Radiother Oncol; 2012 Sep; 104(3):367-73. PubMed ID: 22981610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
    Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
    Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
    Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
    J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer.
    Muratore A; Zimmitti G; Lo Tesoriere R; Mellano A; Massucco P; Capussotti L
    Eur J Surg Oncol; 2009 Jun; 35(6):588-92. PubMed ID: 19162429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease--results from a review of 82 consecutive cases diagnosed between 1992 and 2004.
    Jabbour J; Cumming R; Scolyer RA; Hruby G; Thompson JF; Lee S
    Ann Surg Oncol; 2007 Jun; 14(6):1943-52. PubMed ID: 17356954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection.
    Zhu WG; Xua DF; Pu J; Zong CD; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Wang CS; Yu CH; Yi JG; Su XL; Ding JX
    Radiother Oncol; 2012 Sep; 104(3):361-6. PubMed ID: 22985776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
    Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
    Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.
    Kim TH; Park SR; Ryu KW; Kim YW; Bae JM; Lee JH; Choi IJ; Kim YJ; Kim DY
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e585-92. PubMed ID: 22975616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].
    Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R
    Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging.
    Kong SH; Lee HJ; Ahn HS; Kim JW; Kim WH; Lee KU; Yang HK
    Ann Surg; 2012 Jan; 255(1):50-8. PubMed ID: 21577089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
    Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
    Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.